Insider · CIK 0001600301
Rajesh Asarpota
Files at MRVI (MARAVAI LIFESCIENCES HOLDINGS, INC.), PFSA (Profusa, Inc.). First filing -, latest -.
In brief
Rajesh Asarpota files SEC Form 4 as CFO and director at MRVI (MARAVAI LIFESCIENCES HOLDINGS, INC.), and also at PFSA (Profusa, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rajesh Asarpota has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | FTax withholding Class A Common Stock | -5,465 | $7.65 | $42k | 418,021 | 12 d ago |
| Aug 31, 2026 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | FTax withholding Class A Common Stock | -5,465 | $7.68 | $42k | 423,486 | 42 d ago |
| Jul 30, 2026 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | FTax withholding Class A Common Stock | -5,465 | $6.59 | $36k | 428,951 | Aug 3, 2026 |
| Jun 30, 2026 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | FTax withholding Class A Common Stock | -65,584 | $6.39 | $419k | 434,416 | Jul 1, 2026 |
| Jan 26, 2026 | PFSA Profusa, Inc. | AGrant or award Stock Optionsderivative | +221,794 | $0.00 | $0 | 221,794 | Jan 28, 2026 |
| Jan 26, 2026 | PFSA Profusa, Inc. | AGrant or award Stock Optionsderivative | +52,866 | $0.00 | $0 | 52,866 | Jan 28, 2026 |
| Jun 30, 2025 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | AGrant or award Class A Common Stock | +500,000 | - | - | 500,000 | Jun 30, 2025 |
| Jun 30, 2025 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | AGrant or award Employee Stock Option (Right to Buy)derivative | +333,333 | $0.00 | $0 | 333,333 | Jun 30, 2025 |
| Jun 30, 2025 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | AGrant or award Performance Stock Unitsderivative | +750,000 | $0.00 | $0 | 750,000 | Jun 30, 2025 |
Questions about Rajesh Asarpota
Answered from the filings on this page, as of the latest one.
Is Rajesh Asarpota buying or selling?
Rajesh Asarpota has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rajesh Asarpota's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rajesh Asarpota has 0.
Where does Rajesh Asarpota file Form 4?
Rajesh Asarpota has filed Form 4 at MRVI (MARAVAI LIFESCIENCES HOLDINGS, INC.) as Chief Financial Officer; PFSA (Profusa, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.